In 2011 the INS, Infusion Nurse Society released their latest “Infusion Nursing Standards of Practice” Many changes in recommendations of how we care for infusion patients were made in this [...]
Nuedexta® (dextromethorphan hydrobromide and quinidine) was the first medication approved by the FDA for the treatment of pseudobulbar affect (PBA). Pseudobulbar affect is a specific [...]
Before a prescription drug manufacturer can promote a medication for a specific indication they must conduct extensive clinical trials demonstrating safety and effectiveness. The FDA (Food and [...]
A guiding principle in geriatrics is to assume that any symptom in an elderly adult is a drug side effect until proven otherwise. Diabetic patients often experience symptoms of neuropathy, either [...]
Proton pump inhibitors (PPIs) constitute a class of drugs used short-term (4-8-weeks) to provide a pronounced and prolonged reduction in gastric acid production allowing gastric and duodenal [...]